← All trends
Confidence: StrongAs of 2026-07-10
global · market pattern
Ozempic: rising in 1 market, falling in 8
Ozempic is moving in opposite directions by market: accelerating in 1 tracked markets while declining in 8. Same product, different lifecycle stage.
The same wellness product is booming in some countries and fading in others. Here is the map for Ozempic.
What it isthe semaglutide brand for diabetes and weight loss
Working hypothesisAI-suggested
Ozempic search is fading in its early-adopter markets (Brazil, Germany, UK) as the brand name gives way to generic semaglutide and to Mounjaro.
The evidence
- accelerating
- accelerating in vietnam [MEASURED]
- declining
- declining in brazil, germany, netherlands, sweden, australia [MEASURED]
- read
- same concept, opposite six-month concordance by market, is itself the signal, Western-mature versus other-market takeoff
- note
- Concordance and six-month change are measured per market. The lifecycle read is INFERRED.
The full ranking
8 tracked · ozempic by market.
- 1Us Nationalcresting/plateau, -17% 6mo, 778K/mo
- 2Mexicomixed/noisy, -1% 6mo, 446K/mo
- 3Brazildeclining, -53% 6mo, 368K/mo
- 4Polandmixed/noisy, -9% 6mo, 351K/mo
- 5Spainsteady-growth, +14% 6mo, 316K/mo
- 6Francemixed/noisy, +0% 6mo, 295K/mo
- 7Germanydeclining, -8% 6mo, 292K/mo
- 8Italysteady-growth, +53% 6mo, 257K/mo